Gurrin, L., Bertalli, N., Dalton, G., Osborne, N., Constantine, C., McLaren, C., . . . Fletcher, A. (2009). HFE C282Y/H63D Compound Heterozygotes Are at Low Risk of Hemochromatosis-Related Morbidity. John Wiley & Sons Inc.
Chicago Style (17th ed.) CitationGurrin, L., et al. HFE C282Y/H63D Compound Heterozygotes Are at Low Risk of Hemochromatosis-Related Morbidity. John Wiley & Sons Inc, 2009.
MLA (9th ed.) CitationGurrin, L., et al. HFE C282Y/H63D Compound Heterozygotes Are at Low Risk of Hemochromatosis-Related Morbidity. John Wiley & Sons Inc, 2009.
Warning: These citations may not always be 100% accurate.